MPM BioVentures 2014 reports $612,948 Entrada Therapeutics common share sale

Reuters2026/08/31 22:25

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

MPM BioVentures 2014, a 10% owner of Entrada Therapeutics, sold 86,914 common shares from Aug. 27-31, 2026.
Sales were reported at weighted-average prices of $7.2, $7.01, $6.99 per share.
Beneficial ownership fell to 4,231,434 shares following the Aug. 31 transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-001135), on August 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

MPM BioVentures 2014 reports $612,948 Entrada Therapeutics common share sale

You may also like

Crypto prices